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Background: Amblyopia is a visual condition that occurs in childhood. Screening programmes exist within the
United Kingdom (UK) to detect amblyopia, and once detected treatment is given.
Existing patient reported outcome (PRO) measures for amblyopia do not meet current recommendations for the
methods adopted during their development, or the way in which the instruments are administered. The overall aim
of this study was to produce a self-complete PRO instrument for amblyopia for children aged 4–7 years that uses
children’s responses in the development phase. The study comprised a number of stages. This paper reports on the
refinement of the descriptive system for the draft instrument (the Child Amblyopia Treatment Questionnaire,
CAT-QoL) using qualitative and quantitative methods.
Methods: The study consisted of three components. Children were asked to read, and complete the draft
questionnaire as independently as possible. They were then asked about the questionnaire, and its format, in a
cognitive debriefing exercise. Observations were made as to the child’s ability to read the questionnaire, particular
attention was made as to which individual words participants struggled to read. Children were also asked their
opinion on the design layout of the questionnaire. Finally, some children were asked to complete a ranking task to
help determine the order of the levels of the items as judged by the children. Mid-rank scoring and statistical level
of agreement were calculated for the ranking exercise.
Results: Thirty-two (n=32) participants completed a draft questionnaire; each of these underwent a cognitive de-briefing
interview. Twenty-two (n=22) children completed the ranking exercise. Ten children did not understand the concept of
ranking. The results of the qualitative phase (cognitive de-briefing interview) were used to modify the wording of items
and layout of the instrument. Results of the ranking exercise were used to inform the order of the response levels for the
items.
Conclusion: Responses of young children can be used in the development of PRO instruments. They are able to help
inform the content, wording, and format of an instrument, ensuring good content and face validity. The results have
been used to further refine the CAT-QoL, however further research is required to assess the psychometric properties of
the instrument.
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The use of patient-reported outcome (PRO) measures is in-
creasing. They provide information which may be used to
aid clinical decision making or resource allocation. New
PRO instruments are being developed, or modified, to assess
the impact of a condition or disease. With such an influx of
instruments available to researchers and clinicians, it can be
difficult to determine which instrument is most appropriate.
The COSMIN initiative (COnsensus-based Standards for
the selection of health Measurement INstruments) was de-
veloped to improve the selection of health measurements.
The COSMIN checklist was developed through an inter-
national Delphi study, and specifically addressed the lack of
agreement between terminology and definition of measure-
ment properties [1]. These included the three domains of re-
liability, validity and responsiveness, all of which should be
evaluated when assessing the psychometric properties of a
PRO instrument. Traditionally, the psychometric assessment
of PRO instruments has been reported in the literature, with
little or no reference to the development of the instrument
itself. However recent recommendations from the US De-
partment of Health and Human Services Food and Drug
Administration (FDA) are that there should be evidence
from qualitative studies to demonstrate that the items of an
instrument are appropriate to the target population, and ad-
vocate instrument development history to be available [2].
They state that the purpose of a PRO instrument is “to cap-
ture the patient experience, an instrument will not be a
credible measure without evidence of its usefulness from the
target population of patients” [2].
Amblyopia is a visual condition that occurs in childhood.
Screening programmes exist within the United Kingdom
(UK) to detect amblyopia, and once detected treatment is
given. Treatment primarily consists of glasses, patch, drops,
or any combination of these. There are advantages and dis-
advantages to the different treatment options, and these
may influence treatment choice. Due to the maturing na-
ture of the visual system, treatment is more successful if
completed before the age of 7 years. This falls within an im-
portant time of a child’s personal, social and educational de-
velopment. A systematic review of the literature showed
that amblyopia and/or its treatment does affect an individ-
ual’s health-related quality of life (HRQoL) [3]. The ways in
which these were reported varied, both in terms of the in-
struments used, and the respondent. Few of the studies
identified in the review reported from the patient’s (child’s)
perspective. Although proxy-reported PRO measures are
used in healthcare, they do have limitations. They may con-
tain items (questions) that require a parent/guardian to
make a judgement on what their child is experiencing. This
may not be the same as what the child is experiencing. A
parent’s judgement may be influenced by how important
they perceive the activity to be (such as school work, or
interacting with friends); or how important they judge thetreatment itself. Furthermore, parental reporting can
introduce potential bias based upon how the disease im-
pacts upon the parent themselves [4]. Two disease-specific
PRO instruments were identified in the literature review
that could be used to assess the HRQoL implications of
amblyopia the Amblyopia and Strabismus Questionnaire
(A&SQ) and the Amblyopia Treatment Index (ATI) [5].
Both instruments were designed specifically for the ambly-
opic population and have been accepted within the clinical
community as being valid and reliable [6-9]. The A&SQ
and ATI were developed using a “top-down” methodo-
logical approach; that is, the content of the instrument
was determined by previous literature and clinical opinion.
A disadvantage of the A&SQ is that it is administered to
adults, so cannot be used to assess the implications of am-
blyopia and/or its treatment from the child’s perspective.
Furthermore, it contains questions that relate to strabis-
mus. Strabismus is an abnormal alignment of one or both
eyes (also known as a squint), and has different HRQoL
implications to amblyopia. The ATI is more likely to be
sensitive to encapsulating the HRQoL implications of am-
blyopia, as it does not address issues of strabismus (unlike
the A&SQ); yet this instrument also has some potential
weaknesses when considering its application to the paedi-
atric population. It is a proxy-reported instrument, and
was initially designed for that purpose. However, in a re-
cent study the Pediatric Eye Disease Investigator Group
(PEDIG) used the ATI to assess the impact of treatment in
children aged 7–13 years [10]. Parents and children both
completed the ATI and the results were compared. The
psychometric properties of the two ATI versions were
reported to be similar, however the authors acknowledged
that the validity of the child version has yet to be formally
been assessed.
No disease-specific PRO instrument is available to as-
sess the implications of amblyopia treatment from the
child’s perspective that satisfies the recommendations of
the FDA and COSMIN Initiative. The overall aim of this
study was to produce a paediatric disease-specific health
related quality of life (HRQoL) instrument for amblyopia
that could be used in research or routine clinical prac-
tice. The study comprised a number of phases, the re-
sults of which have been reported. Firstly, a systematic
literature review was undertaken to identify the HRQoL
implications of amblyopia and/or its treatment [3]. The
results of the literature review were used to create a
topic guide used in focus groups conducted with clini-
cians (orthoptists) [11]. The focus group sessions were
undertaken to identify any additional HRQoL implica-
tions of amblyopia and/or its treatment which had not
been identified in the literature review. The results of
the literature review and focus group sessions were used
to create a topic guide for semi-structured interviews
conducted with children with amblyopia. The interviews
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atric disease-specific HRQoL instrument for amblyopia
[12]. This paper reports on the refinement of the de-
scriptive system for the draft questionnaire (the Child
Amblyopia Treatment Questionnaire, CAT-QoL) using
qualitative and quantitative methods.Methods
Eleven possible themes had been identified for possible in-
clusion in the draft instrument following qualitative analysis
of semi-structured interviews conducted with children with
amblyopia [12]. These are listed in Table 1. Analysis of the
interview data identified potential themes for inclusion in
the CAT-QoL instrument; however, the response levels for
the items (questions) had not yet been determined. The
interview transcripts were re-examined and the terminology
the children used when describing the impact of amblyopia
and/or its treatment upon their HRQoL informed the
choice of levels for the items (questions). The phrases that
the children used were “a little bit”; “a bit”, “quite a bit”;
“quite”; “a lot”; “really”; and “very”. The transcripts were re-
examined to establish which phrases had been used by the
children interviewed for each of the given items shown in
Table 1. Not every phrase was used when the children
discussed their feelings about each possible item, and there-
fore three categories of questions (A, B and C) with differ-
ent item response scales were established (Table 1). The
item response scales were applied to each of the 11 items,
to form an 11-item instrument that consisted of six item re-
sponse levels.Table 1 Potential item for the CAT-QoL instrument
1 Item Category
2 Physical sensation of the treatment (e.g. feeling of the
patch/glasses on the face, or the feeling of the drops
being instilled)
A
3 Pain of treatment (hurt) A
4 Being able to play with other children A
5 How other children have treated them (like laughing or
name-calling)
A
6 Ability to undertake work at school B
7 Ability to undertake other tasks (like playing on the
computer, colouring, playing games, watching TV)
B
8 Feeling sad or unhappy B
9 Feeling cross B
10 Feeling worried B
11 Feeling frustrated B
12 Feelings towards family members (like parents
or siblings)
C
A not; a little bit; a bit; quite a bit; a lot; really.
B not; a little bit; a bit; quite; really; very.
C not; a little bit; a bit; quite a bit; really, very.Two draft versions of the questionnaire were developed.
These were the same in content but differed in format. One
version had the completion tick-box at the start of the item
statement (version 1). The other version had the comple-
tion tick-box at the end of the item statement (version 2).
Seven different treatment-specific versions were created
(patch; drops; glasses; patch and drops; patch and glasses;
glasses and drops; glasses, patch and drops). It was neces-
sary to have treatment-specific versions to word the ques-
tions appropriately.
The 11-item draft questionnaires were piloted in a
clinical setting at two National Health Service (NHS)
sites within Sheffield, United Kingdom (UK). The pur-
pose of the pilot was to refine the content, wording and
format of the CAT-QoL instrument, before a multi-
centre validation study. The pilot consisted of three
components and involved: completing a draft question-
naire; cognitive debriefing interview; and ranking exer-
cise. Children were asked to read, and complete the
draft questionnaire as independently as possible. The
children were then asked about the questionnaire, and
its format, in a cognitive debriefing exercise. Finally,
some children were asked to complete a ranking task to
help determine the order of the levels of the items as
judged by the children. Each participant was given either
Version 1 (tick-box at the end of the item statement) or
Version 2 (tick-box at the start of the item statement) to
complete.
Cognitive debriefing
Children were also asked to participate in a cognitive
debriefing process. Cognitive debriefing is a process
whereby participants are asked to explain their think-
ing, or understanding of a question. The process is used
in the development of questionnaires to help identify
and correct problems with survey questions [13].
Within this study, participants were asked to explain
what they believed the question was asking them. The
results were recorded, and clarification sought where
applicable. Observations were also made as to the
child’s ability to read the questionnaire itself. Particular
attention was made as to which individual words the
participants struggled to read. Children were also asked
their opinion on the design layout of the questionnaire,
specifically whether the item check-box should be
placed at the beginning or the end of each level re-
sponse (Version 1 vs. Version 2) (Additional file 1).
Example of item check-box location
Version 1
□ My patch did not hurt me.
Version 2
My patch did not hurt me… … … … … … … … … …□
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response levels
Qualitative analysis of the interview data identified the pos-
sible item response levels to be used in the instrument.
However, it was important to determine the order of the
response levels for the content of the questionnaire from a
child’s perspective. To achieve this, a ranking exercise was
undertaken. Ranking involves participants ordering a list of
statements starting from least (affected) to worst (affected).
The item response levels are printed on separate cards,
and participants are asked to place these in an order that
they believe to be correct. Ideally, participants would rank
the order of response levels for every item within a ques-
tionnaire. However, it was felt that it would be too lengthy
a process to ask a child to rank the order of levels for each
of the 11 possible items in the draft questionnaire. Instead,
one question was chosen from each of the categories (A, B
and C). The questions chosen were “hurt”, “cross” and
“upset with family”. The items “hurt” (Question 3) and
“cross” (Question 5) were chosen as it was felt that these
were easy words for participants to read. There was only
one Category C question (Question 9). Participants were
asked to rank the order of severity from least to worst.
When a card was ranked first, it was scored 1; when
ranked second it was scored 2; and so on. Where cards
were ranked as being equal, each tied ranking was given a
value of the midpoint as the previous two marks (mid rank
method) [14]. This approach ensures that the sum of the
ranks is maintained.
The mean rank order was calculated for each response
level, for each of the category questions (A, B and C).
The difference between the mean rank scores was then
calculated. A small difference between the mean rank
scores of the item response levels indicates that the two
levels are thought of as being the same conceptually. A
mean rank value of less than 0.2 was taken to mean a
small difference between response levels. This approach
was in line with that adopted by Stevens during the de-
velopment of the Child Health Utility 9D (CHU9D)
questionnaire (a generic paediatric HRQoL instrument)
[15]. The rank data was also analysed by using Kendall’s
coefficient of concordance test statistic. This is a meas-
ure of agreement between variables, and is recorded as a
value between 0 (no agreement) and 1 (complete agree-
ment). The Kendall’s coefficient of concordance test
statistic measured the amount of agreement between
participants on how they ranked the order of the re-
sponse levels for the questions used in the ranking task.
Landis and Koch use categories to define levels of agree-
ment (for the Kappa statistic, another statistical meas-
ure of agreement) [16]. Each question was assessed in
terms of the level of agreement (Poor < 0; Slight 0.00 –
0.20; Fair 0.21 – 0.40; Moderate 0.41 – 0.60; Substantial
0.61 – 0.80; and Almost Perfect 0.81 – 1.00).The study was approved by the NHS Research Ethics
Committee (REC Ref: 07/Q1201/5), and followed the te-
nets of the Declaration of Helsinki. The inclusion criteria
were that adopted for the semi-structured interviews, and
the same recruitment technique was adopted [12]. It was
not possible to identify before clinical examination poten-
tial participants, and therefore purposive sampling of the
eligible study population was not possible. Instead, an op-
portunistic recruitment (and therefore opportunistic sam-
pling) approach was undertaken. Full written consent was
obtained from the parent/guardian before the child partic-
ipated in the study.
Results
Thirty-two (n=32) participants completed a draft question-
naire, and each of these underwent a cognitive de-briefing
interview. All of the participants in the pilot sample were
white. The majority of the participants (n=26) had mild
level of amblyopia (using the PEDIG model of amblyopia
classification) [17-21]. Mild amblyopia was categorised as
0≥0.30 logMAR; moderate amblyopia 0.31≥0.60 logMAR;
and severe amblyopia >0.61 logMAR). Only 3 participants
had a moderate level of amblyopia; the remaining 3 partici-
pants did not have their vision assessed at the time of the
pilot, and therefore their level of amblyopia severity could
not be classified. Eleven participants completed version 1
of the questionnaire, and 19 participants were issued with
version 2. Of the 32 participants, all were on some form of
treatment (glasses only n=13; patch only n=1; patch and
glasses n=16; glasses and drops n=2)). Of the study sample,
22 children were able to complete the ranking exercise
(Table 2). Ten children did not understand the concept of
the ranking exercise, and this exercise was abandoned for
these participants.
Practicality of the instrument
Of the 32 children who took part in the study, 29 com-
pleted the questionnaire. Two children did not complete
the entire questionnaire due to time constraints (n=2).
One questionnaire was abandoned as the child was un-
responsive (n=1). Of the 29 children who completed the
questionnaire, 13 were able to read the questionnaire
themselves (either in its entirety or with limited assist-
ance). A number of children had to have the question-
naire read to them, as they had had drops in their eyes
for a routine glasses check (n=5). This meant their vi-
sion was blurry and they were unable to read the text it-
self. It is not certain whether these children would have
been able to self-complete the questionnaire if the drops
had not been instilled. The remaining 11 children had
the questionnaire read to them. This was mainly at their
request. Of the children who completed the question-
naire themselves (n=13), each responded to every ques-
tion, giving a 100% completion rate.
Table 2 Study participants for pilot of draft questionnaire
N Sex Number of participants age (yrs)
5 6 7 8 9
Completed Questionnaire and Cognitive Debriefing 32 16 male, 16 female 14 8 5 4 1
Version1 11 5 male, 6 female 7 2 1 1 0
Version 2 19* 10 male, 9 female 8* 6 3 1 1
Able to self-complete 4 1 5 3 1
Questionnaire read to them 9 4 0 1 0
Questionnaire read to them due to drops 1 3 0 0 0
Ranking Exercise 22 11 male, 11 female 8 4 5 4 1
Unable to complete ranking 10 5 male, 5 female 6 4 0 0 0
* abandoned in one participant.
Table 3 Mean rank, standard deviation, minimum and






My drops did not hurt me A 1.00 0.00 1 1
My drops hurt me a little bit A 2.45 0.77 1.5 4
My drops hurt me a bit A 3.00 0.65 1.5 4
My drops hurt me quite a bit A 3.59 0.77 2 4
My drops hurt me a lot A 5.36 0.52 4.5 6
My drops really hurt me A 5.59 0.43 4.5 6
My drops did not make me
feel cross
B 1.05 0.21 1 2
My drops made me feel a little
bit cross
B 2.36 0.71 1 4
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As part of the cognitive de-briefing process, each child was
asked if there were any additional questions that should be
included. They were asked whether there was “anything
else” that they could not do because of their specific eye
treatment; and whether they had any other feelings about
their eye treatment that had not been asked. One child said
that they “bumped into things” because of their patch and
glasses. Another said that their patch and glasses felt
“tickly”, and that their patch and glasses made them feel
“happy”. One child said that they “couldn’t sit far away
from the whiteboard at school” because of their patch and
glasses. Another child said that they felt “annoyed” due to
their treatment. Some of the children needed some assist-
ance reading particular words. These included “worried”,
“frustrated” (annoyed, cross), “laughing”, “question”, “each”,
“choices”, “yesterday”, and “bothered”. Some children
needed the meaning of some questions explained to them.
These questions were “feeling worried”, “upset with my
family”, “feeling frustrated”.My drops made me feel a
bit cross
B 2.89 0.55 2 3.5
My drops made me feel
quite cross
B 3.70 0.63 2 4
My drops made me feel
really cross
B 5.55 0.41 5 6
My drops made me feel
very cross
B 5.45 0.41 5 6
My drops have not made me get
upset with my family
C 1.00 0.00 1 1
My drops have made me get
upset with my family a little bit
C 2.50 0.71 2 4
My drops have made me get
upset with my family a bit
C 2.91 0.72 2 5
My drops have made me get
upset with my family quite a bit
C 3.73 0.83 2 6
My drops have really made me get
upset with my family
C 5.20 0.70 3 6
My drops have made me get very
upset with my family
C 5.61 0.43 5 6Ranking exercise
The results for the mean rank, standard deviation, mini-
mum and maximum position for each question are
shown in Table 3. Table 4 shows the mean rank order
and the difference in mean rank order between the
levels. A small difference between the ranking scores in-
dicates that the participants view the two levels to have
a similar meaning. In the category A question (hurt)
there is little difference between “my drops hurt me a
lot” and “my drops really hurt me” to be the same (as
shown by a difference of 0.23). The results show that
within the category B question (cross), “my drops made
me feel really cross” and “my drops made me feel very
cross” were valued as being the same (difference of
−0.09). The negative value indicates that “very” can be
placed above “really”. Table 5 shows the Kendall coeffi-
cient for each question. The Kendall coefficient is “sub-
stantial” for the category A (hurt) and category C (upsetwith my family) questions, and “almost perfect” for the
category B (cross) question (using Landis & Koch defini-
tions [16]). This indicates that children are able to rank
the order of the levels, and that statistically, the order-
ing of the levels (as shown in Table 3) is “correct”.
Table 4 Mean rank order and the difference in mean rank




My drops did not hurt me 1.00 1.45
My drops hurt me a little bit 2.45 0.55
My drops hurt me a bit 3.00 0.59
My drops hurt me quite a bit 3.59 1.77
My drops hurt me a lot 5.36 0.23
My drops really hurt me 5.59
My drops did not make me feel cross 1.05 1.32
My drops made me feel a little bit cross 2.36 0.52
My drops made me feel a bit cross 2.89 0.82
My drops made me feel quite cross 3.70 1.84
My drops made me feel really cross 5.55 −0.09
My drops made me feel very cross 5.45
My drops have not made me get upset with
my family
1.00 1.50
My drops have made me get upset with my
family a little bit
2.50 0.41
My drops have made me get upset with my
family a bit
2.91 0.82
My drops have made me get upset with my
family quite a bit
3.73 1.48
My drops have really made me get upset
with my family
5.20 0.41
My drops have made me get very upset
with my family
5.61
Table 5 Kendall coefficient for questions
Question Kendall coefficient
Category A (hurt) 0.795
Category B (cross) 0.836
Category C (upset with my family) 0.755
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A number of modifications were made to the initial ques-
tionnaire driven by the results of the cognitive de-briefing
and ranking exercises. The main alterations are discussed
here. Firstly, the results of the ranking data analysis were
used to determine both the number of levels and order of
the levels for the items. Despite there being a possibility
that participants believe “my drops hurt me a lot” and “my
drops really hurt me” to be thought of as the same (as
shown by a difference of 0.23), category A questions were
kept as a 6-part response scale. However, all category B
questions were reduced to a 5-part response scale, with
the “really” level removed. Table 4 shows the mean rank
order, and the difference in the mean rank order between
the levels. For the “cross” question, the small difference in
mean rank order indicates that children could not distin-
guish much difference between “really” cross and “very”
cross. It could be interpreted that one of these levels is re-
dundant, and a decision was made to remove one from
the draft instrument. “Really” was chosen as it was felt this
could be considered a colloquial term. When this response
option was removed, this 5 response level options
remained: “did not”, “a little bit”, “a bit”, “quite”, “very”. As“cross” was a Category B question, all other category B
questions were revised so that they too had 5 response
levels.
The wording of one question was modified (“upset with
my family”) due to comments during the cognitive de-
briefing. Participants reported that they did feel upset due
to their treatment, but not necessarily upset with their
family. The interview transcripts were re-examined to
consider this. It can be argued that “upset” should be used
as an item; just as “sad” is. The items are the consequence
of the treatment, and not a description of why they feel that
emotion. The question was therefore changed from “My
patch has not made me get upset with my family” to “My
patch has not made me feel upset”. Once the “with my fam-
ily” was removed, and the term “feel” rather than “get” ap-
plied, some of the original response levels no longer made
sense (“My drops have made me feel quite a bit upset”).
And so the “a bit” was dropped, leaving “quite”. This meant
the response options for the question were “did not”, “a lit-
tle bit”, “a bit”, “quite”, “really”, “very”; which were the same
as that of the Category B question, and therefore the Cat-
egory C question was re-categorised to B. The responses
options Category B questions were modified in response to
the difference in mean rank order as outlined above, and
therefore 5 response level options were applied.
One question was omitted in its entirety from the draft
questionnaire (“feeling frustrated”). The majority of partici-
pants in the cognitive de-briefing had to have the concept
of “frustration” explained to them. Even after an explan-
ation was given, some children still did not understand
what was meant by the term. One additional question was
included in the draft questionnaire (“happy”). As part of
the de-briefing process, participants were asked if they felt
anything else about their patch, drops and/or glasses. A
number of children reported that they felt happy. The tran-
scripts of the interviews with children were then re-
examined, and analysed again to explore the possibility of
happy as an item in the questionnaire. This had not been
originally included in the draft questionnaire as it was as-
sumed that “happy” was the opposite of “sad”. However, as
the aim of this study was to develop an instrument by chil-
dren, for children, the cognitive de-briefing responses were
noted and this item was added.
Other minor modifications included changing individual
words to make it easier for the child to understand or
read; or reducing the number of words for a given ques-
tion where possible. The purpose was to make the overall
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fied version of questionnaire, and Additional file 3 for full
details of all modifications made).
Discussion
The literature on the development of the descriptive sys-
tem for PRO instruments is relatively sparse. This re-
search describes some of the processes undertaken to
refine the draft descriptive system of the CAT-QoL instru-
ment. This is in line with recommendations of the FDA
for development of PRO measures [2]. The aim of the
study was to further refine the draft descriptive system,
prior to a multi-centre pilot and validation study, after
which the final CAT-QoL instrument would be developed.
Practicalities of the instrument: task burden
Language comprehension and reading ability are import-
ant factors, particularly if they are to “self-complete” the
questionnaire [22]. The reading ability of the children
who completed the piloting of the draft questionnaire
was not assessed in this study. It is acknowledged that
the degree to which a child can self-complete a ques-
tionnaire is dependent upon their ability. Matza et al.
advise that younger children may require assistance with
reading the questionnaire, and the administration proce-
dures [4].
Format of the instrument: number of items
The format of the questionnaire in terms of length, and
item level scales are other issues to consider. The num-
ber of items included in a PRO instrument contributes
to the response burden of the task. It is acknowledged
that older children can be expected to complete longer
measures [4]; with the intended target population of 4–7
year old, the draft CAT-QoL instrument could be de-
scribed as having a low task burden.
Format of the instrument: response levels – frequency or
severity scales?
PRO instruments can differ in their response scale options.
They may be based upon severity, frequency, or the level
of agreement with something (strongly agree, strongly dis-
agree). The severity scale was chosen for the CAT-QoL for
two reasons. Firstly, the data collected during the inter-
views with the children lends itself to this approach. Chil-
dren spoke of how bad something was, rather than how
often it occurred. Secondly, using a frequency scale would
involve the child having to accurately consider a given time
period. Children’s abilities to reliably report on their health
within specific time frames have been investigated. Predict-
ably, older children are more accurately able to demon-
strate a longer recall period [22,23]. Although a time frame
has been set for the CAT-QoL instrument (“in the last
week”), it was felt that using frequency item scale wouldresult in less accurately reported data. Severity scales have
been used successfully in other paediatric PROs, such as
the CHU9D [15].
A time frame has been set for the CAT-QoL instrument
(“in the last week”). Other paediatric PROs, such as the
PedsQLTM, use a time frame of in the “last few weeks”. The
CHU9D uses a time frame of “today”. Consideration was
made of the intended population (children aged 4 to 7
years), so a time frame of the “last few weeks” was deemed
too long to be able to accurately recall. A time frame of
“today” was not chosen, as a potential participant may re-
ceive the CAT-QoL instrument early in the day, before they
have had time to undertake their amblyopia treatment and
wear their patch (or glasses, etc.).
Format of the instrument: response levels – number of
response scale points
The number of response scale points within a PRO instru-
ment is important to consider. Matza et al. state that youn-
ger children show significantly more extreme responses
than older children [4]. However, children aged 8 years have
been shown to accurately use a 5-part or 7-part response
scale [24]. The number of response scale points in the draft
version of the CAT-QoL was informed initially from the
child interview data, and revised following the pilot and
ranking exercise. The results of the ranking exercise dem-
onstrated that young children were able to rank severity in
a way that appears conceptually coherent. This is a novel
approach in the development of response scales options for
PRO instruments for young children.
Format of the instrument: layout
Some questionnaires, such as the PedsQL™ child report use
a smiley face to illustrate the difference in response options
[25]. Similarly, the Child Health and Illness Profile (CHIP)
use circles of increasing size and illustrations to show the
extreme responses the child can give [22]. The impact of
response scale options upon reliability and reproducibility
has been investigated using the TedQL instrument (a gen-
eric child self-report instrument) [26]. In a study on
healthy children, Creemens et al. reported that young chil-
dren (aged 5–6 years) showed better reliability (agreement
in responses over time, test-retest reliability) using a
thermometer type response scale. The use of pictures, or
circles of increasing size, was not adopted for the CAT-
QoL layout for a number of reasons. It was felt children
may interpret a smiley face to be how they feel on that day,
rather than a reflection of how they have felt about the
item. Some children also associate sad faces with negative
connotations. For example, a smiley face often denotes
“happy”. A child may not answer a question on “hurt” cor-
rectly, as they may respond with a “sad” face, as they per-
ceive “hurt” to be a negative concept. In this case, they
would not be reporting upon their HRQoL. Children in
Carlton Health and Quality of Life Outcomes 2013, 11:174 Page 8 of 9
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the end of the item statement (Version 2).
Limitations of the study
This research is not without limitations. The number of
participants in the pilot of the draft version of the descrip-
tive system was small, and the number of those who par-
ticipated in the ranking exercise of the response levels was
smaller still. It could be argued that more participants
should have been included during this phase of the instru-
ment development. However, a larger number of children
were involved in the prior phase (identification of poten-
tial items through semi-structured interviews) [12].
Furthermore, the classification of amblyopia adopted for
the study is arbitrary. There are universally agreed defini-
tions of what level of visual acuity equates to mild, moder-
ate, and severe amblyopia. The categorisation approach
used here was that described by the PEDIG group; a col-
laborative network who facilitate multi-centre clinical re-
search in eye disorders that affect children. The PEDIG
group have published widely in the field of amblyopia, and
have conducted a number of multi-centre studies examin-
ing the efficacy of amblyopia treatment [17-21]. The ma-
jority of participants in this study had mild level of
amblyopia, and it could be argued that more participants
should have been included to reflect the full spectrum of
amblyopia severity.
Conclusions
The aim of this paper was to describe the methods used to
refine a disease-specific HRQoL instrument designed for
children aged 4–7 years with amblyopia. This research has
demonstrated that young children are able to ensure face
validity of a PRO. Children were used at every stage of the
development of the descriptive system. Interview data dir-
ectly informed the items of the instrument; the response
levels of the instrument; and the wording of the instru-
ment. Comments given by the children during the cogni-
tive de-briefing process were also used to alter the layout
and format of the measure itself. This approach ensured
the content validity and face validity of the instrument are
high. This adheres to the recommendations of the FDA
who observe that issues for PRO instruments applied to
children include “age-related vocabulary, language compre-
hension, comprehension of the health concept measured,
and duration of recall” [2]. Further research is required to
formally assess the draft descriptive system, and subse-
quent refinement may be necessary. The draft descriptive
system outlined here is not the final content of the CAT-
QoL instrument. The draft descriptive system comprised of
eleven items, with either five or six severity response op-
tions. However, the final number of items, and the number
of response level options for each item will be explored fol-
lowing a multi-centre pilot and validation study. Assessmentof the psychometric properties of the final CAT-QoL instru-
ment should also be conducted. Further details on the CAT-
QoL instrument can be found at www.cat-qol.org.
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